Your browser doesn't support javascript.
loading
Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries.
Morris, Joan K; Wellesley, Diana; Limb, Elizabeth; Bergman, Jorieke E H; Kinsner-Ovaskainen, Agnieszka; Addor, Marie Claude; Broughan, Jennifer M; Cavero-Carbonell, Clara; Dias, Carlos M; Echevarría-González-de-Garibay, Luis-Javier; Gatt, Miriam; Haeusler, Martin; Barisic, Ingeborg; Klungsoyr, Kari; Lelong, Nathalie; Materna-Kiryluk, Anna; Neville, Amanda; Nelen, Vera; O'Mahony, Mary T; Perthus, Isabelle; Pierini, Anna; Rankin, Judith; Rissmann, Anke; Rouget, Florence; Sayers, Geraldine; Stevens, Sarah; Tucker, David; Garne, Ester.
Afiliação
  • Morris JK; St George's, University of London, London, United Kingdom.
  • Wellesley D; Clinical Genetics, University of Southampton and Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
  • Limb E; St George's, University of London, London, United Kingdom.
  • Bergman JEH; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
  • Kinsner-Ovaskainen A; European Commission, Joint Research Centre (JRC), Ispra, Italy.
  • Addor MC; Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.
  • Broughan JM; National Disease Registration Service, NHS Digital, Leeds, United Kingdom.
  • Cavero-Carbonell C; Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.
  • Dias CM; Department of Epidemiology, Instituto Nacional de Saúde Doutor Ricardo Jorge; Av padre Cruz, Lisbon, Portugal.
  • Echevarría-González-de-Garibay LJ; Ministry of Health of the Basque Government, Directorate for Healthcare Planning, Organisation and Evaluation, Vitoria-Gasteiz, Spain.
  • Gatt M; Directorate for Health Information and Research, Malta Congenital Anomalies Registry, G'Mangia, Malta.
  • Haeusler M; Medical University of Graz, Austria.
  • Barisic I; Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.
  • Klungsoyr K; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
  • Lelong N; Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.
  • Materna-Kiryluk A; Université de Paris, INSERM U1153, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Paris, France.
  • Neville A; Polish Registry of Congenital Malformations, Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
  • Nelen V; Center for Clinical and Epidemiological Research, University of Ferrara, Ferrara, Italy.
  • O'Mahony MT; Provincial Institute for Hygiene, Antwerp, Belgium.
  • Perthus I; Department of Public Health, Health Service Executive-South, Cork, Ireland.
  • Pierini A; Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, CNRS-UMR 6602, Institut Pascal, Axe TGI, équipe PEPRADE, Clermont-Ferrand, France.
  • Rankin J; Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.
  • Rissmann A; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
  • Rouget F; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Sayers G; Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
  • Stevens S; Brittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
  • Tucker D; Health Intelligence, Research and Development Health Service Executive, Dublin, Ireland.
  • Garne E; National Disease Registration Service, NHS Digital, Leeds, United Kingdom.
Birth Defects Res ; 114(20): 1417-1426, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36369770
BACKGROUND: Younger mothers are at a greater risk of having a pregnancy with gastroschisis and the risk is higher in the United Kingdom than other European countries. Gastroschisis is thought to be a vascular disruption anomaly and the aim of this study was to analyze the prevalence of other possible vascular disruption anomalies to determine whether both the younger maternal age and the UK associations also occur with these anomalies. METHODS: All pregnancies with anomalies considered potentially due to vascular disruption from January 1, 2005 to December 31, 2017 from 26 European population-based congenital anomaly registries who were members of EUROCAT were analyzed. Multilevel models were used to allow for differences between registries when analyzing associations with maternal age, year of birth and whether the registry was in the United Kingdom. RESULTS: There were 5,220 cases with potential vascular disruption anomalies, excluding chromosomal and genetic conditions, with a prevalence of 8.85 per 10,000 births in the United Kingdom and 5.44 in the other European countries. The prevalence per 10,000 births of gastroschisis (4.45 vs. 1.56) and congenital constriction bands (0.83 vs. 0.42) was significantly higher in the United Kingdom, even after adjusting for maternal age. However, transverse limb reduction defects had a similar prevalence (2.16 vs. 2.14 per 10,000). The expected increased prevalence in younger mothers was observed for vascular disruption anomalies overall and for the individual anomalies: gastroschisis and congenital constriction bands. CONCLUSION: Vascular disruption anomalies that had an increased risk for younger mothers (such as gastroschisis) had a higher maternal age standardized prevalence in the United Kingdom, while vascular disruption anomalies with weaker associations with younger mothers (such as transverse limb reduction defects) did not have an increased prevalence in the United Kingdom, which may indicate a different etiology for these anomalies.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anormalidades Cardiovasculares / Gastrosquise / Malformações Vasculares Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Birth Defects Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Anormalidades Cardiovasculares / Gastrosquise / Malformações Vasculares Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: Birth Defects Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido